In conclusion, it seems that cancer stem cells, based on the type of tumor and its stroma, may express several markers, such as those seen in lung cancer, with adenocarcinomas showing CD133 overexpression and squamous cell carcinomas showing ALDH1 overexpression (32). This evidence concerns the gene PROM1 and neoplasm.